Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism Spectrum Disorders (ASDs)

Overview

Journal J Cent Nerv Syst Dis

Publisher Sage Publications

Date 2014 Sep 25

PMID 25249767

Citations 19

Authors

Anthony J Russo

Affiliations

Soon will be listed here.

Abstract

Background: One in 88 children in the US is thought to have one of the autism spectrum disorders (ASDs). ASDs are characterized by social impairments and communication problems. Growth factors and their receptors may play a role in the etiology of ASDs. Research has shown that epidermal growth factor receptor (EGFR) activation is associated with nerve cell development and repair. This study was designed to measure plasma levels of EGFR in autistic children and correlate these levels with its ligand, epidermal growth factor, other related putative biomarkers such as hepatocyte growth factor (HGF), the ligand for MET (MNNG HOS transforming gene) receptor, as well as the symptom severity of 19 different behavioral symptoms.

Subjects And Methods: Plasma EGFR concentration was measured in 33 autistic children and 34 age- and gender-similar neurotypical controls, using an enzyme-linked immunosorbent assay. Plasma EGFR levels were compared to putative biomarkers known to be associated with EGFR and MET and severity levels of 19 autism-related symptoms.

Results: We found plasma EGFR levels significantly higher in autistic children, when compared to neurotypical controls. EGFR levels correlated with HGF and high-mobility group protein B1 (HMGB1) levels, but not other tested putative biomarkers, and EGFR levels correlated significantly with severity of expressive language, conversational language, focus/attention, hyperactivity, eye contact, and sound sensitivity deficiencies.

Conclusions: These results suggest a relationship between increased plasma EGFR levels and designated symptom severity in autistic children. A strong correlation between plasma EGFR and HGF and HMGB1 suggests that increased EGFR levels may be associated with the HGF/Met signaling pathway, as well as inflammation.

Citing Articles

A Systems Biology Approach for Prioritizing ASD Genes in Large or Noisy Datasets.

Remori V, Bondi H, Airoldi M, Pavinato L, Borini G, Carli D Int J Mol Sci. 2025; 26(5).

PMID: 40076702 PMC: 11900372. DOI: 10.3390/ijms26052078.

Curation of causal interactions mediated by genes associated with autism accelerates the understanding of gene-phenotype relationships underlying neurodevelopmental disorders.

Iannuccelli M, Vitriolo A, Licata L, Lo Surdo P, Contino S, Cheroni C Mol Psychiatry. 2023; 29(1):186-196.

PMID: 38102483 PMC: 11078740. DOI: 10.1038/s41380-023-02317-3.

A study of genetic heterogeneity in autism spectrum disorders based on plasma proteomic and metabolomic analysis: multiomics study of autism heterogeneity.

Tang X, Feng C, Zhao Y, Zhang H, Gao Y, Cao X MedComm (2020). 2023; 4(5):e380.

PMID: 37752942 PMC: 10518435. DOI: 10.1002/mco2.380.

Differential variability analysis of single-cell gene expression data.

Liu J, Kreimer A, Li W Brief Bioinform. 2023; 24(5).

PMID: 37598422 PMC: 10516347. DOI: 10.1093/bib/bbad294.

Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances.

Golub A, Ordak M, Nasierowski T, Bujalska-Zadrozny M Int J Mol Sci. 2023; 24(11).

PMID: 37298365 PMC: 10253383. DOI: 10.3390/ijms24119413.

References

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J . Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2010; 25(1):40-5. PMC: 2991432. DOI: 10.1016/j.bbi.2010.08.003. View

Kim S, Shin S, Lee K, Joo E, Song J, Ahn Y . The genetic association of DUSP6 with bipolar disorder and its effect on ERK activity. Prog Neuropsychopharmacol Biol Psychiatry. 2011; 37(1):41-9. DOI: 10.1016/j.pnpbp.2011.11.014. View

Iseri E, Guney E, Ceylan M, Yucel A, Aral A, Bodur S . Increased serum levels of epidermal growth factor in children with autism. J Autism Dev Disord. 2010; 41(2):237-41. DOI: 10.1007/s10803-010-1046-3. View

Vargas D, Nascimbene C, Krishnan C, Zimmerman A, Pardo C . Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2004; 57(1):67-81. DOI: 10.1002/ana.20315. View

Russo A, Krigsman A, Jepson B, Wakefield A . Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease. Biomark Insights. 2009; 4:181-90. PMC: 2796865. DOI: 10.4137/bmi.s3656. View

Downward J, Parker P, Waterfield M . Autophosphorylation sites on the epidermal growth factor receptor. Nature. 1984; 311(5985):483-5. DOI: 10.1038/311483a0. View

Liu B, Chen H, Johns T, Neufeld A . Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury. J Neurosci. 2006; 26(28):7532-40. PMC: 6674203. DOI: 10.1523/JNEUROSCI.1004-06.2006. View

Lin C, Du J, Shen W, Whang E, Donner D, Griff N . Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer. J Clin Endocrinol Metab. 2010; 96(3):E554-65. DOI: 10.1210/jc.2010-1800. View

Miettinen P, Berger J, Meneses J, Phung Y, Pedersen R, Werb Z . Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 1995; 376(6538):337-41. DOI: 10.1038/376337a0. View

10.

Levitt P, Campbell D . The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest. 2009; 119(4):747-54. PMC: 2662567. DOI: 10.1172/JCI37934. View

11.

Li X, Chauhan A, Sheikh A, Patil S, Chauhan V, Li X . Elevated immune response in the brain of autistic patients. J Neuroimmunol. 2009; 207(1-2):111-6. PMC: 2770268. DOI: 10.1016/j.jneuroim.2008.12.002. View

12.

Heck D, Laskin D, Gardner C, Laskin J . Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem. 1992; 267(30):21277-80. View

13.

Vezzani A, French J, Bartfai T, Baram T . The role of inflammation in epilepsy. Nat Rev Neurol. 2010; 7(1):31-40. PMC: 3378051. DOI: 10.1038/nrneurol.2010.178. View

14.

Palumbo R, Sampaolesi M, De Marchis F, Tonlorenzi R, Colombetti S, Mondino A . Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol. 2004; 164(3):441-9. PMC: 2172232. DOI: 10.1083/jcb.200304135. View

15.

Enstrom A, Onore C, Van de Water J, Ashwood P . Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun. 2009; 24(1):64-71. PMC: 3014091. DOI: 10.1016/j.bbi.2009.08.001. View

16.

Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer A . Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med. 2010; 16(4):413-9. DOI: 10.1038/nm.2127. View

17.

Mizuno M, Sotoyama H, Namba H, Shibuya M, Eda T, Wang R . ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions. Transl Psychiatry. 2013; 3:e252. PMC: 3641415. DOI: 10.1038/tp.2013.29. View

18.

Menard D, Tremblay E, Ferretti E, Babakissa C, Perron N, Seidman E . Anti-inflammatory effects of epidermal growth factor on the immature human intestine. Physiol Genomics. 2012; 44(4):268-80. DOI: 10.1152/physiolgenomics.00101.2011. View

19.

Herbst R . Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys. 2004; 59(2 Suppl):21-6. DOI: 10.1016/j.ijrobp.2003.11.041. View

20.

Pastore S, Mascia F . Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin. Expert Rev Dermatol. 2009; 3(5):525-527. PMC: 2600505. DOI: 10.1586/17469872.3.5.525. View